
First Nipah Virus Vaccine Enters Human Trials in April
A deadly tropical virus with up to 75% fatality rates finally has a vaccine candidate heading to human trials. Tokyo researchers modified the measles vaccine to protect against Nipah virus, which has killed dozens in recent outbreaks.







